Mortality after total hip replacement surgery

J R Berstock,A D Beswick,E Lenguerrand,M R Whitehouse,A W Blom,J. R. Berstock,A. D. Beswick,E. Lenguerrand,M. R. Whitehouse,A. W. Blom
DOI: https://doi.org/10.1302/2046-3758.36.2000239
IF: 4.41
2014-06-01
Bone and Joint Research
Abstract:Total hip replacement causes a short-term increase in the risk of mortality. It is important to quantify this and to identify modifiable risk factors so that the risk of post-operative mortality can be minimised. We performed a systematic review and critical evaluation of the current literature on the topic. We identified 32 studies published over the last 10 years which provide either 30-day or 90-day mortality data. We estimate the pooled incidence of mortality during the first 30 and 90 days following hip replacement to be 0.30% (95% CI 0.22 to 0.38) and 0.65% (95% CI 0.50 to 0.81), respectively. We found strong evidence of a temporal trend towards reducing mortality rates despite increasingly co-morbid patients. The risk factors for early mortality most commonly identified are increasing age, male gender and co-morbid conditions, particularly cardiovascular disease. Cardiovascular complications appear to have overtaken fatal pulmonary emboli as the leading cause of death after hip replacement. Cite this article: Bone Joint Res 2014;3:175–82
orthopedics,cell & tissue engineering
What problem does this paper attempt to address?